Ned Wakeman
Director and Founder @Nanoptima Limited
Signup · Get unlimited contacts
WORK HISTORY
Director and Founder @Nanoptima Limited
NanOptima is designing and developing innovative and safe intra-ocular depots so that a single injection can controllably release efficacious advanced therapies doses over 6-12 months to halt the progression of chronic, sight-threatening retinal diseases We are designing depots to ensure optical transparency, viscosity for fine-needle (30G) injection, immediate re-gelation inside the eye, and tuning rates of drug release over months to match depot biodegradation
EDUCATION
Colgate University
Bachelor of Arts (B.A.)
California State University, Fresno
Experimental Psychology
University of Oxford
Experimental Psychology - Neuroscience
Yale School of Medicine
Neuropsychopharmacology - research only
California School of Professional Psychology
Clinical Psychology
ABOUT NED WAKEMAN
An accomplished, entrepreneurial and strategic thinking CEO and Director with a wealth of experience influencing solutions across company lifecycles, working with investment and business lines to deliver vision and drive sustainable growth. Proven expertise providing advice to life science companies, driving SME, science park, cluster, and ecosystem development, with a strong track record in investment banking and private placement, venture capital investment, partnership development as well as leveraging sector and client networks. A strong and collaborative leader deploying attention to detail to provide innovative solutions to identified challenges. An excellent communicator, at all levels, who establishes outstanding stakeholder relationships. An influential, pragmatic, and highly personable professional. Conceived and introduced a £250m joint investment, incubation, and property project, delivering a significant FDI involving UK DIT in 2017/2018. Conceived, Directed, and developed Alderley Park Oncology Development Programme (ODP1) and Lean Life Science Oncology Development Programme (ODP2) Founder and CEO of NanOptima, a company focused on developing new technologies to solve major challenges in ocular drug delivery.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.